OV935
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OV935, covering 2021-10-04 to 2021-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Absolute Bioavailability of TAK-935 (OV935) and to Characterize Mass Balance, Pharmacokinetics, Metabolism, and Excretion of [14C]TAK-935 (OV935) in Healthy Male Participants [Phase 1]